文献速递自身炎症与 IgG4 相关病

未分化复发性发热综合征(SURF)治疗反应预测因素与聚类分析

Predictive factors for therapeutic response and cluster analysis in syndrome of undifferentiated recurrent fever (SURF).
PubMed 文献 · RMD Open · 2025-08-10

该研究纵向分析Eurofever登记库中101例未分化复发性发热综合征(SURF)患者,排除PFAPA及已知单基因周期性发热。秋水仙碱在77例中评估,61%完全应答;口腔阿弗他炎为秋水仙碱抵抗的独立预测因素(p=0.014)。IL-1抑制剂对难治病例有益,聚类分析揭示三个亚组。

要点

  • SURF患者中约三分之一 sporadic 出现PFAPA样特征(淋巴结肿大、扁桃体炎、口腔阿弗他)。
  • 秋水仙碱完全应答率61%(77例中),口腔阿弗他炎为抵抗独立预测因素(p=0.014)。
  • IL-1抑制剂(阿那白滞素、卡那单抗)对难治性SURF病例有益。

核心结论

  • SURF中存在秋水仙碱抵抗的预测因素,IL-1阻断显示出疗效,聚类分析提示SURF异质性,支持细化诊断标准和个体化治疗策略。

研究设计与样本

  • 纵向分析Eurofever登记库中101例SURF患者,排除PFAPA、家族性地中海热及其他已知单基因复发性发热。

主要发现

  • 常见症状包括发热、关节痛、腹痛和肌痛,PFAPA样特征(淋巴结肿大、扁桃体炎、口腔阿弗他)在三分之一病例中偶发出现。
  • 秋水仙碱在77例中评估,61%获完全应答。
  • 单变量分析显示口腔阿弗他炎(p=0.001)、颈部淋巴结肿大(p=0.012)和渗出性扁桃体炎(p=0.004)与秋水仙碱抵抗相关。
  • 多变量分析确认口腔阿弗他炎为抵抗的独立预测因素(p=0.014)。
  • 扁桃体切除术无效,IL-1抑制剂(阿那白滞素、卡那单抗)对难治性病例有益。

关键数值与推荐

  • 秋水仙碱完全应答率61%(77例中评估)。
  • 口腔阿弗他炎预测秋水仙碱抵抗的p=0.001(单变量)、p=0.014(多变量)。
  • 颈部淋巴结肿大p=0.012、渗出性扁桃体炎p=0.004与秋水仙碱抵抗相关。

临床怎么用

  • 作者认为IL-1阻断对难治性SURF病例有效。
  • 作者认为聚类分析提示SURF异质性,支持细化诊断标准和个体化治疗策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Syndrome of undifferentiated recurrent fever (SURF) refers to a group of recurrent fevers without a clear monogenic cause. Clinical spectrum, treatment response predictors and management strategies remain unclear. OBJECTIVE: This study aims to longitudinally analyse a homogeneously selected cohort of 101 SURF patients, to identify factors associated with colchicine resistance and to evaluate the efficacy of interleukin-1 (IL-1) inhibitors. METHODS: Patients were enrolled in the Eurofever Registry, carefully excluding those with periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA); familial Mediterranean fever and other known monogenic recurrent fevers. Demographic, clinical and treatment data were analysed to identify predictors of colchicine resistance and define subgroups through cluster analysis. RESULTS: Common symptoms included fever, arthralgia, abdominal pain and myalgia, with PFAPA-like features (lymphadenopathy, tonsillitis, oral aphthae) observed in one-third of cases, sporadically. Colchicine efficacy, assessed in 77 patients, revealed complete response in the majority of patients (61%). Univariable analysis identified PFAPA-like features, including aphthous stomatitis (p=0.001), cervical lymphadenopathy (p=0.012) and exudative tonsillitis (p=0.004), as associated with colchicine resistance. Multivariable analysis confirmed aphthous stomatitis as an independent predictor of resistance (p=0.014). Tonsillectomy was ineffective. IL-1 inhibitors (anakinra, canakinumab) were beneficial in refractory cases. Cluster analysis revealed three distinct subgroups with varying symptoms and colchicine responses. CONCLUSIONS: These findings provide new insights into SURF, identifying predictors of colchicine resistance and supporting the efficacy of IL-1 blockade. Cluster analysis suggests the heterogeneity within SURF, reinforcing the need for refined diagnostic criteria and personalised treatment strategies.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Palmeri S, Ponzano M, Recchi G, et al. Predictive factors for therapeutic response and cluster analysis in syndrome of undifferentiated recurrent fever (SURF). RMD Open. 2025. PMID: 40784758. doi:10.1136/rmdopen-2025-005874

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。